Kuster, S., Jordan, S., Elhai, M., Held, U., Steigmiller, K., Bruni, C., Cacciapaglia, F., Vettori, S., Siegert, E., Rednic, S., Codullo, V., Airo, P., Braun-Moscovici, Y., Hunzelmann, N., Joao Salvador, M., Riccieri, V., Gheorghiu, A., Alegre Sancho, J. J., Romanowska-Prochnicka, K., Castellví, I., Kötter, I., Truchetet, M., López-Longo, F., Novikov, P. I., Giollo, A., Shirai, Y., Belloli, L., Zanatta, E., Hachulla, E., Smith, V., Denton, C., Ionescu, R. M., Schmeiser, T., Distler, J. H. W., Gabrielli, A., Hoffmann-Vold, A., Kuwana, M., Allanore, Y., & Distler, O. (2022). effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD open, 8(2), . http://access.bl.uk/ark:/81055/vdc_100169182291.0x000003